JOHN GILL

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN GILL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Altimmune, Inc. Director Common Stock, par value $0.0001 12,500 $51,249 $4.10 23 Dec 2025 Direct
Altimmune, Inc. Director Stock Options (option to buy) 48,800 25 Sep 2025 Direct

Insider Reports Filed by JOHN GILL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALT Altimmune, Inc. 23 Dec 2025 1 +$51,250 4 Director 23 Dec 2025, 16:10
ALT Altimmune, Inc. 25 Sep 2025 2 $0 4 Director 29 Sep 2025, 16:17
ALT Altimmune, Inc. 26 Sep 2024 1 $0 4 Director 30 Sep 2024, 18:34
ALT Altimmune, Inc. 28 Sep 2023 1 $0 4 Director 29 Sep 2023, 17:00
ALT Altimmune, Inc. 29 Sep 2022 1 $0 4 Director 30 Sep 2022, 21:21
ALT Altimmune, Inc. 12 Aug 2022 1 -$40,710 4 Director 06 Jul 2023, 18:00
ALT Altimmune, Inc. 31 Dec 2021 3 $0 5 Director 14 Feb 2022, 16:01
ALT Altimmune, Inc. 23 Sep 2021 1 $0 4 Director 24 Sep 2021, 20:45